Hyperglycolysis is a typical signature of both inflammatory and cancer cells; we then firstly compared the real-time kinetics of glycolysis by measuring the extracellular acidification rate (ECAR) in control and PDIA2-knockdown cells using the glycolytic stress assay. This evidence concerns the gene PDIA2 and cancer.